Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2537-2552
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2537
Table 5 Satisfaction with perianal fistula treatments
Cohort 2
Cohort 3
CPF no surgery
(n = 174)
CPF with surgery
(n = 135)
Satisfaction with PF treatments (on a scale of 1-9), mean ± SD, % rated ≥ 7
    Medication6.5 (1.4), 57a6.4 (1.5), 50a
    Long-term seton placement6.7 (1.5), 57b6.2 (1.7), 47c
    Endorectal/anal advancement flap6.2 (1.7), 52a6.3 (1.7), 52a
    Fibrin glue6.4 (1.9), 61a6.2 (1.6), 45a
    Anal fistula plug6.6 (1.8), 66a6.5 (1.6), 56a
    Fistulectomy/fistulotomy6.9 (1.6), 68a6.3 (1.9), 50a
    LIFT (ligation of intersphincteric fistula tract)6.7 (1.5), 65a6.2 (1.7), 46a
Satisfaction with PF treatment attributes (on a scale of 1-9), mean ± SD, % rated ≥ 7
    Aids in closure of external opening of the fistulas6.4 (1.5), 48a6.5 (1.6), 55a
    Reduction or no drainage6.4 (1.6), 54a6.4 (1.6), 51a
    Time required for symptom improvement6.3 (1.6), 54a6.3 (1.7), 50a
    Time required for rehabilitation6.2 (1.7), 51a6.2 (1.8), 52a
    Length of duration before symptom(s) recur6.3 (1.7), 52a6.3 (1.8), 52a
    Has minimal side effects (local pain, redness, itchiness)6.2 (1.9), 54a6.3 (1.8), 53a
    Minimal risk of fecal incontinence6.3 (1.7), 51a6.4 (1.7), 53a
    Not requiring a long-term seton placement6.4 (1.7), 52a6.6 (1.7), 59a
    Less invasive nature of treatment (not requiring incision)6.4 (1.7), 56a6.3 (1.8), 48a